Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04145635 · ClinicalTrials.gov registry record · NA
The Aortix CRS Pilot Study
A NA study, sponsored by Procyrion.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT04145635: Completed NA study, sponsored by Procyrion.
NCT04145635 is a NA study that has completed, run by Procyrion. The registered enrollment target is 21 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04145635, a NA study, has completed, sponsored by Procyrion.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The Aortix CRS Pilot Study: An Evaluation of the Safety and Performance of the Aortix System for Intra-Aortic Mechanical Circulatory Support in Patients with Cardiorenal Syndrome
Primary Outcome
Rate of Occurrence of Serious Adverse Events (rate will be calculated and reported)
Interventions
- DEVICE Aortix System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2021-02-05 |
| Est. Completion | 2023-03-09 |
| Phase | NA |
What the finished NCT04145635 record still lists
NCT04145635 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 21 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Aortix System is the first listed.
NCT04145635 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04145635 about?
NCT04145635 is a clinical study titled "The Aortix CRS Pilot Study". The Aortix CRS Pilot Study: An Evaluation of the Safety and Performance of the Aortix System for Intra-Aortic Mechanical Circulatory Support in Patients with Cardiorenal Syndrome
What is the current status of trial NCT04145635?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2021-02-05. Estimated completion is 2023-03-09.
What interventions are being tested in trial NCT04145635?
The interventions under investigation include: Aortix System (DEVICE).
Who is sponsoring clinical trial NCT04145635?
This trial is sponsored by Procyrion, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04145635's enrollment target sits among peer trials
21 1762nd of 2000 higher than 233 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI